Cargando…
Evaluation of (188)Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model
PURPOSE: In this study, the (188)Re-labeled PEGylated nanoliposome ((188)Re-liposome) was prepared and evaluated as a therapeutic agent for glioma. MATERIALS AND METHODS: The reporter cell line, F98(luc) was prepared via Lentivector expression kit system and used to set up the orthotopic glioma-bear...
Autores principales: | Huang, Feng-Yun J, Lee, Te-Wei, Chang, Chih-Hsien, Chen, Liang-Cheng, Hsu, Wei-Hsin, Chang, Chien-Wen, Lo, Jem-Mau |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296959/ https://www.ncbi.nlm.nih.gov/pubmed/25624760 http://dx.doi.org/10.2147/IJN.S75955 |
Ejemplares similares
-
Rhenium-188 Production in Hospitals, by W-188/Re-188 Generator, for Easy Use in Radionuclide Therapy
por: Argyrou, Maria, et al.
Publicado: (2013) -
(188)Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy
por: Boschi, Alessandra, et al.
Publicado: (2017) -
Translating Research for the Radiotheranostics of Nanotargeted (188)Re-Liposome
por: Chang, Chih-Hsien, et al.
Publicado: (2021) -
Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated (188)Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor
por: Lin, Bing-Ze, et al.
Publicado: (2020) -
External beam radiotherapy synergizes (188)Re-liposome against human esophageal cancer xenograft and modulates (188)Re-liposome pharmacokinetics
por: Chang, Chih-Hsien, et al.
Publicado: (2015)